Roland Brüning
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 11, 2025
Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience.Carolin M Reiner, Martin A Schneider, Hauke Weilert
|Mar 25, 2022
Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.Peter Raab, Rouzbeh Banan, Arash Akbarian
|Jan 11, 2022
Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience.Cornelia L A Dewald, Mia-Maria Warnke, Roland Brüning
|Aug 04, 2021
Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.Rouzbeh Banan, Arash Akbarian, Majid Samii
|May 17, 2021
Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales.Roland Brüning, Martin Schneider, Michel Tiede
|Sep 16, 2020
Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan-Long-Term Overall Survival Negatively Correlates with Tumor Burden.R Brüning, M Tiede, M Schneider
Pageof 1
Frequent Collaborators
1 joint publications
Cornelia L A Dewald
1 joint publications
Jan B Hinrichs
1 joint publications
Anna Saborowski
1 joint publications
Arndt Vogel
1 joint publications
Peter Raab
1 joint publications
Joachim K Krauss
1 joint publications
Heinrich Lanfermann
1 joint publications
Andreas H Mahnken
1 joint publications
Axel Stang
